LON:APH Alliance Pharma (APH) Share Price, News & Analysis GBX 46 +0.30 (+0.66%) (As of 07:50 AM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades About Alliance Pharma Stock (LON:APH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Alliance Pharma alerts:Sign Up Key Stats Today's Range 45.51▼ 46.4550-Day Range 42.90▼ 4952-Week Range 24.55▼ 50.26Volume169,009 shsAverage Volume1.47 million shsMarket Capitalization£248.66 millionP/E RatioN/ADividend Yield4.35%Price TargetGBX 60Consensus RatingBuy Company OverviewAlliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.Read More… Alliance Pharma Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks67th Percentile Overall ScoreAPH MarketRank™: Alliance Pharma scored higher than 67% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingAlliance Pharma has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageAlliance Pharma has received no research coverage in the past 90 days.Read more about Alliance Pharma's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Alliance Pharma is -766.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alliance Pharma is -766.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioAlliance Pharma has a PEG Ratio of 1.04. PEG Ratios around 1 indicate that a company is correctly valued.Price to Book Value per Share RatioAlliance Pharma has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for APH. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipAlliance Pharma is a leading dividend payer. It pays a dividend yield of 3.75%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthAlliance Pharma does not have a long track record of dividend growth.Read more about Alliance Pharma's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for APH. News and Social Media3.2 / 5News SentimentN/A News SentimentAlliance Pharma has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Alliance Pharma this week, compared to 0 articles on an average week.Search Interest32 people have searched for APH on MarketBeat in the last 30 days. This is an increase of 19% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Alliance Pharma insiders have not sold or bought any company stock.Percentage Held by Insiders11.95% of the stock of Alliance Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions66.34% of the stock of Alliance Pharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Alliance Pharma's insider trading history. Receive APH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address APH Stock News Headlinesbonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US marketDecember 12, 2024 | markets.businessinsider.comAlliance Pharma reports 'strong' performance after turbulent few monthsSeptember 30, 2024 | msn.comCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.December 24, 2024 | Brownstone Research (Ad)Alliance Pharma (LON:APH) adds UK£38m to market cap in the past 7 days, though investors from three years ago are still down 58%September 12, 2024 | finance.yahoo.comHalf Year Trading UpdateJuly 31, 2024 | lse.co.ukAIM-listed Alliance Pharma axes chief operating officer roleJuly 23, 2024 | msn.comAlliance Pharma PLC (DVL.SG)May 24, 2024 | sg.finance.yahoo.comAlliance Pharma delays results again and chief executive exitsMay 9, 2024 | msn.comSee More Headlines APH Stock Analysis - Frequently Asked Questions How have APH shares performed this year? Alliance Pharma's stock was trading at GBX 40.50 on January 1st, 2024. Since then, APH stock has increased by 13.6% and is now trading at GBX 46. View the best growth stocks for 2024 here. How do I buy shares of Alliance Pharma? Shares of APH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Alliance Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alliance Pharma investors own include boohoo group (BOO), BP (BP), Vodafone Group Public (VOD), Aviva (AV), Babcock International Group (BAB), BAE Systems (BA) and The Gym Group (GYM). Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryElectronic Equipment Current SymbolLON:APH CUSIPN/A CIKN/A Webwww.alliancepharma.co.uk Phone+44-1249-466966FaxN/AEmployees91,000Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 60 High Stock Price TargetGBX 60 Low Stock Price TargetGBX 60 Potential Upside/Downside+30.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)GBX (0.06) Trailing P/E RatioN/A Forward P/E Ratio8.86 P/E Growth1.04Net Income£-33,580,000.00 Net Margins-18.34% Pretax MarginN/A Return on Equity-13.44% Return on Assets5.98% Debt Debt-to-Equity Ratio47.46 Current Ratio2.93 Quick Ratio1.42 Sales & Book Value Annual Sales£183.15 million Price / Sales1.36 Cash FlowGBX 5.85 per share Price / Cash Flow7.87 Book ValueGBX 41 per share Price / Book1.12Miscellaneous Outstanding Shares540,570,000Free FloatN/AMarket Cap£248.66 million OptionableNot Optionable Beta0.67 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report This page (LON:APH) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredSix Stocks That Could Soar on Trump’s First Day BackThe recent election results have clarified a path forward, creating opportunities that weren't as clear just m...InvestorPlace | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alliance Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Alliance Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.